Benedikt Judmann

Toward the Development of GE11-Based Radioligands for Imaging of Epidermal Growth Factor Receptor-Positive Tumors

G. Fricker, B. Wängler, R. Schirrmacher, 2022, ACS omega.

Synthesis, Radiolabeling, and In Vitro and In Vivo Characterization of Heterobivalent Peptidic Agents for Bispecific EGFR and Integrin αvβ3 Targeting

G. Fricker, B. Wängler, R. Schirrmacher, 2023, ACS omega.

Side-by-Side Comparison of Five Chelators for 89Zr-Labeling of Biomolecules: Investigation of Chemical/Radiochemical Properties and Complex Stability

G. Fricker, B. Wängler, R. Schirrmacher, 2021, Cancers.

Towards Radiolabeled EGFR-Specific Peptides: Alternatives to GE11

G. Fricker, B. Wängler, R. Schirrmacher, 2023, Pharmaceuticals.

Current State of Radiolabeled Heterobivalent Peptidic Ligands in Tumor Imaging and Therapy

G. Fricker, B. Wängler, R. Schirrmacher, 2020, Pharmaceuticals.

PESIN Conjugates for Multimodal Imaging: Can Multimerization Compensate Charge Influences on Cell Binding Properties? A Case Study †

C. Dallanoce, B. Wängler, R. Schirrmacher, 2021, Pharmaceuticals.